Matt Martin writes to help compounding pharmacies navigate the Food and Drug Administration’s (FDA’s) recently finalized guidance document Insanitary Conditions at Compounding Facilities.

PCCA's Formulation Development team is populated with hard-working, dedicated pharmacy professionals who strive each day to make a difference in pharmacy compounding. As a team, they act as a key component of PCCA's abiding desire to provide pharmacies with formulas that alleviate patient health challenges. The Formulation Development Spotlight is a limited series of articles designed to highlight a singular member of the formula development team. This article focuses on Melissa Merrell Rhoads.

PCCA provides clarity and guidance regarding the Food and Drug Administration (FDA) sharing its version of what a memorandum of understanding (MOU) between it and the various states would look like.